Starbucks Corp. (0QZH)
London Exchange · UK · prices in USD · close of 20 Oct 2026
Key indicators
| Last close | USD 99.70 |
|---|---|
| 52-week range | 76.07 – 111.83 |
| Return, 1 month / 3 months | +5.4% / −2.9% |
| Return, 1 year / 3 years | +23.2% / +18.0% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 61 |
| Volatility (1 year) | 28.0% |
| Worst drawdown (1 year) | -17.7% |
| Average daily value traded | 0.64M USD |
| Dividend yield | 2.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Starbucks is a coffee company that runs a chain of coffeehouses around the world. It serves hot and cold coffee drinks, espresso-based beverages, teas, and other refreshments, along with food such as pastries, sandwiches and snacks. Its customers are everyday consumers who visit its cafes or order through its mobile app and delivery partners. The company is based in Seattle in the United States and also sells packaged coffee and related goods through retail channels.
The shares are listed on the London Exchange in UK under the code 0QZH, and the price on this page is in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Starbucks Corp. (0QZH) trades on the London Exchange in UK. It last closed at USD 99.70 on 20 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 1,225 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 23.2% and over the last three months it fell 2.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 58 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 1.2% | ||
| From 52-week high | -9.1% | ||
| Momentum | 55 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -2.9% | ||
| 6-month return | 3.7% | ||
| 12-month return, skipping the last month | 16.8% | ||
| Stability (higher is calmer) | 73 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 28.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.7% | ||
| Liquidity | 48 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.64M USD | ||
| Zero-volume days | 1.7% | ||
| Income | 75 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 2.5% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +8.3% |
|---|---|
| 1 month | +5.4% |
| 3 months | −2.9% |
| 6 months | +3.7% |
| 1 year | +23.2% |
| 3 years | +18.0% |
| 5 years | – |
Signals
| 50-day / 200-day average | 99.88 / 98.53 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.72 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Aug 2026 | USD 0.6200 |
| 14 May 2026 | USD 0.6200 |
| 12 Feb 2026 | USD 0.6200 |
| 13 Nov 2025 | USD 0.6200 |
| 14 Aug 2025 | USD 0.6100 |
| 15 May 2025 | USD 0.6100 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.